BIDOLI PAOLO

Role: 
Associate professor
Academic disciplines: 
MEDICAL ONCOLOGY (MED/06)

Publications

  • Bani, M., Rossi, E., Cortinovis, D., Russo, S., Gallina, F., Hillen, M., et al. (2021). Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale. EUROPEAN JOURNAL OF CANCER CARE, 30(1).
  • Massironi, S., Pilla, L., Elvevi, A., Longarini, R., Rossi, R., Bidoli, P., et al. (2020). New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma. CELLS, 9(3).
  • Molina-Vila, M., Stahel, R., Dafni, U., Jordana-Ariza, N., Balada-Bel, A., Garzón-Ibáñez, M., et al. (2020). Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial. JOURNAL OF THORACIC ONCOLOGY, 15(3), 416-425.
  • Alberti, A., Mancin, M., Cortinovis, D., Bidoli, P., & Sala, L. (2020). Disseminated intravascular coagulation in advanced lung adenocarcinoma during first-line pembrolizumab. IMMUNOTHERAPY, 12(9), 629-633.
  • Barni, S., Rosati, G., Lonardi, S., Pella, N., Banzi, M., Zampino, M., et al. (2020). Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 12.